Biotech Business - June 2, 2025
Bristol Myers Squibb receives European Commission approval for Opdivo
Opdivo is the first and only PD-1 inhibitor approved for subcutaneous (SC) use in the European Union.
Business article - May 30, 2025
European Commission adopts startup and scaleup strategy
The European Commission has launched the EU Startup and Scaleup Strategy, ‘Choose Europe to Start and Scale', to make Europe a great place to start and grow global technology-driven companies.
Global report - May 27, 2025
The world’s first Pandemic Agreement adopted
The decision by the 78th World Health Assembly culminates more than three years of intensive negotiations launched by governments in response to the devastating impacts of the COVID-19 pandemic.
Global report - May 27, 2025
The US administration blocks Harvard from enrolling foreign students
Kristi Noem, Homeland Security Secretary, stated that the administration had revoked Harvard's "Student and Exchange Visitor Program certification as a result of their failure to adhere to the law."
Global report - May 26, 2025
Doing business in the world’s new life science powerhouse
In a sector long dominated by the US and Europe, Mainland China is now catching up in global pharma and biotechnology.
Collaboration - May 21, 2025
The European life science industry: The time to step up is now
Europe ranks highly when it comes to life science know-how and knowledge, but the region is falling behind when it comes to R&D and turning science into real-world solutions. Complex regulations, a fragmented market, scattered funding, and the potential US market tariffs are just some of the challenges ahead.
